<prompt> TNFα inhibitors should not be used in :Rheumatoid arthritis with HIV infectionRheumatoid arthritis with hepatitis BRheumatoid arthritis with hepatitis CRheumatoid arthritis with pulmonary fibrosis  <response>: Anti-TNF α drugs should be avoided inPulmonary tuberculosisMultiple sclerosisHepatitis BCongestive heart failureAnti -TNF-α drugs like infliximab, etanercept and adalimumab are used in rheumatoid arthritis and increase the risk of bacterial infections. These can lead to reactivation of latent tuberculosis. Infliximab rarely, results in leucopenia, activation of hepatitis B and vasculitis. 